Results 271 to 280 of about 705,258 (293)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Redox Biology, 2018
Clémence Cheignon, Peter Faller, Christelle Hureau   +2 more
exaly  

Neutrino–nuclear responses for astro-neutrinos, single beta decays and double beta decays

Physics Reports, 2019
Jouni Suhonen, Kai Zuber
exaly  

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Lancet, The, 2002
Mauro Bergui
exaly  

Amyloid beta: structure, biology and structure-based therapeutic development

Acta Pharmacologica Sinica, 2017
Ting-Hai Xu, Karsten Melcher, H Eric Xu
exaly  

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Per Soelberg Sørensen, Thor Petersen, Egon Stenager   +2 more
exaly  

Verapamil and beta cell function in adults with recent-onset type 1 diabetes

Nature Medicine, 2018
Fernando Ovalle, Guanlan Xu, Peng Li
exaly  

Multiple Regression — Beta Coefficients, Correlations, and Standard Deviations

2023
openaire   +1 more source

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

Lancet Oncology, The, 2018
Ruth Ladenstein, Ulrike Pötschger, Roberto Luksch   +2 more
exaly  

Beta-Diversity in Tropical Forest Trees

Science, 2002
Richard Condit, Nigel Pitman, Jerome Chave   +2 more
exaly  

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2004
Massimo Filippi, Marco Rovaris, Matilde Inglese   +2 more
exaly